Gastroenterology
Conference Coverage
Low-dose aspirin provokes no flares in patients with IBD during pregnancy
Study provides more data on the safety of aspirin use during pregnancy in patients with IBD.
Latest News
GLP-1 RAs tied to suboptimal bowel prep, repeat colonoscopy
“Specifically, for every 14 patients treated with GLP-1 RAs, one patient would require a repeat colonoscopy due to suboptimal preparation.”
Latest News
New insights into how omega-3 fatty acids improve NASH
BTC was consistently upregulated in liver cancer and downregulated by omega-3 polyunsaturated fatty acids in mice and humans with NASH.
Latest News
Surgery is falling out of favor in rectal cancer
“This case series shows that rectal cancer is increasingly being managed medically,” the authors said.
From the Journals
Use the stool! Fecal microbiota transplants help kids with diarrheal infection
“When we think about the microbiome it makes sense to target kids, because they’re more apt to respond to these therapies. I worry that somebody...
Sponsored Supplement
Three Clinical Studies Demonstrating Safety and Efficacy of Treatment for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) in Adults
From the Journals
Fibromyalgia, CFS more prevalent in patients with IBS
“We as clinicians should integrate in our practice with regular screening for other somatic disorders in the IBS population ...”
Conference Coverage
Low-dose aspirin reduces liver fat, inflammation markers
“I’m encouraged by the results with low-dose aspirin, and I think that, given the risk profile, using a lower dose is preferable.”
From the Journals
People with diabetes have a higher risk of colon cancer: Study
The authors concluded that increased referrals for colonoscopies among people with diabetes, particularly among those newly diagnosed, could...
Latest News
Chronic diarrhea management: Be wary of false diarrhea
After ruling out false diarrhea, clinicians should be vigilant for warning signs.
Conference Coverage
Weight-loss drugs improve liver measures, too
Body weight reduction of at least 3% within 8 weeks of beginning treatment with either an SLT-2 or GLP-1 agent was associated independently with...
Latest News
Jury still out on whether green tea lowers colon cancer risk
Combining random trials so far shows no advantage from green tea. But there may still be a benefit.